What does Enanta Pharmaceuticals, Inc. do?

Jun 22 2025 06:32 PM IST
share
Share Via
Enanta Pharmaceuticals, Inc. is a biotechnology company focused on developing small molecule drugs for viral infections and liver diseases. As of March 2025, it reported net sales of $15 million and a net loss of $23 million, with a market cap of $150.70 million.
Overview:
Enanta Pharmaceuticals, Inc. is a research and development-focused biotechnology company in the Pharmaceuticals & Biotechnology industry, specializing in small molecule drugs for viral infections and liver diseases.

Financial Snapshot:
Most recent Net Sales: 15 Million (Quarterly Results - Mar 2025)
Most recent Net Profit: -23 Million (Quarterly Results - Mar 2025)
Market cap: USD 150.70 Million (Micro Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -0.36
Return on Equity: -103.08%
Price to Book: 1.61

Contact Details:
Address: 500 Arsenal St, WATERTOWN MA: 02472-2806
Tel: ['1 617 6070800', '1 617 6070710']
Fax: 1 617 6070530
Website: https://www.enanta.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Enanta Pharmaceuticals, Inc. overvalued or undervalued?
Sep 20 2025 06:11 PM IST
share
Share Via
Is Enanta Pharmaceuticals, Inc. overvalued or undervalued?
Jun 25 2025 08:46 AM IST
share
Share Via
How big is Enanta Pharmaceuticals, Inc.?
Jun 22 2025 05:53 PM IST
share
Share Via